_256_384.jpg){kind=logo}
News | July 04, 2022
Microsize launched as Independent pharma services company
Meets the growing need for US-based API solubility and bioavailability enhancement services
Meets the growing need for US-based API solubility and bioavailability enhancement services
Govt committed to supporting pharma companies with industry-friendly policies
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
Lacosamide Injection is used to treat partial-onset seizures.
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Subscribe To Our Newsletter & Stay Updated
